{
    "nct_id": "NCT05892146",
    "age": "Adults",
    "cancer_center_accrual_goal_upper": 0,
    "curated_on": "2023-06-07",
    "study_start_date": "2021-05-05",
    "study_completion_date": null,
    "data_table4": "Interventional",
    "drug_list": {
        "drug": [
            {
                "drug_name": "Drug: Prevention therapy"
            },
            {
                "drug_name": "Drug: Rescue therapy"
            }
        ]
    },
    "long_title": "Strategy Therapy on Early Phase Cancer Therapeutics-Related Cardiac Dysfunction Patients",
    "last_updated": "2023-06-07",
    "management_group_list": {
        "management_group": [
            {
                "is_primary": "Y",
                "management_group_name": "Group1"
            }
        ]
    },
    "oncology_group_list": {
        "oncology_group": [
            {
                "group_name": "Group1",
                "is_primary": "N"
            }
        ]
    },
    "phase": "NA",
    "principal_investigator": "Ping-Yen Liu, MD, PhD",
    "principal_investigator_institution": "National Cheng Kung University Hospital, Tainan, Taiwan",
    "program_area_list": {
        "program_area": [
            {
                "is_primary": "Y",
                "program_area_name": "Program1"
            }
        ]
    },
    "protocol_id": 0,
    "protocol_ids": [],
    "protocol_no": "",
    "protocol_target_accrual": 100,
    "protocol_type": "INTERVENTIONAL",
    "prior_treatment_requirements": [
        "Inclusion Criteria:",
        "* Patients who are newly diagnosed with breast cancer or lymphoma and never accepted anti-cancer therapy",
        "* Age 20-65 years old",
        "* Systolic blood pressure \u2265 110 mmHg",
        "Exclude - Exclusion Criteria:",
        "Exclude - * End-stage renal disease (estimated Glomerulus Filtration Rate \\<15 mL/min/1.73 m2)",
        "Exclude - * Echocardiography Baseline left ventricle ejection fraction \\< 50%",
        "Exclude - * Allergy history to angiotensin receptor blockers",
        "Exclude - * Life expectancy \\< 1 year",
        "Exclude - * Pregnancy",
        "Exclude - * Unwilling to participate in this clinical study"
    ],
    "short_title": "Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction",
    "site_list": {
        "site": []
    },
    "sponsor_list": {
        "sponsor": [
            {
                "is_principal_sponsor": "Y",
                "sponsor_name": "National Cheng-Kung University Hospital",
                "sponsor_protocol_no": "",
                "sponsor_roles": "sponsor"
            }
        ]
    },
    "staff_list": {
        "protocol_staff": []
    },
    "status": "open to accrual",
    "summary": "The investigators use the cancer registration system of National Cheng Kung University Hospital to timely screen and evaluate those patients having breast cancer or lymphoma to enroll patients to participate in this clinical trial. The investigators planned an earlier initiation of Sacubitril/Valsartan treatment on breast cancer and lymphoma patients before the chemotherapy, and starting therapeutic intervention by Sacubitril/Valsartan once the heart damage sign appeared via novel echocardiography. The investigators aim to assess the protective and therapeutic benefit of cardioprotective drugs on the cardiotoxicity of anti-cancer therapy.",
    "treatment_list": {
        "step": [
            {
                "step_internal_id": 111,
                "step_code": "1",
                "step_type": "Registration",
                "arm": [
                    {
                        "arm_code": "Prevention therapy",
                        "arm_internal_id": 0,
                        "arm_description": "Sacubitril/Valsartan (25/80) mg twice a day for 1 year",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Prevention therapy",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    },
                    {
                        "arm_code": "Conventional therapy",
                        "arm_internal_id": 1,
                        "arm_description": "No intervention",
                        "arm_suspended": "N",
                        "dose_level": []
                    },
                    {
                        "arm_code": "Global longitudinal strain (GLS) function decreased >15%, No intervention",
                        "arm_internal_id": 2,
                        "arm_description": "With the value of GLS function via echocardiography study decreased \\>15%, No intervention",
                        "arm_suspended": "N",
                        "dose_level": []
                    },
                    {
                        "arm_code": "GLS function descending >15%, Rescue therapy",
                        "arm_internal_id": 3,
                        "arm_description": "Sacubitril/Valsartan (25/80) mg twice a day for 1 year",
                        "arm_suspended": "N",
                        "dose_level": [
                            {
                                "level_code": "0",
                                "level_description": "Drug: Rescue therapy",
                                "level_internal_id": 0,
                                "level_suspended": "N"
                            }
                        ]
                    }
                ],
                "match": [
                    {
                        "and": [
                            {
                                "or": [
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "Breast Ductal Carcinoma In Situ"
                                        }
                                    },
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "Metaplastic Breast Cancer"
                                        }
                                    },
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "Invasive Breast Carcinoma"
                                        }
                                    },
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "Lymphoid Neoplasm"
                                        }
                                    },
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "Breast Neoplasm, NOS"
                                        }
                                    },
                                    {
                                        "clinical": {
                                            "oncotree_primary_diagnosis": "Inflammatory Breast Cancer"
                                        }
                                    }
                                ]
                            },
                            {
                                "clinical": {
                                    "age_numerical": ">=20",
                                    "disease_status": [
                                        "Untreated"
                                    ]
                                }
                            }
                        ]
                    }
                ]
            }
        ]
    }
}